A first-in-human phase I trial with antibody drug conjugate ADCT-701 in neuroendocrine tumors and carcinomas.

ADCT-701 - ADC Therapeutics

https://meetings.asco.org/abstracts-presentations/241691/

Jaydira Del Rivero; John Glod; Tamika Magee; Kimberley Cooper; Anna Rivero; Tea Lanfranconi; Rashmika Patel; W Douglas Figg Sr.; Yves Pommier; Brigitte Widemann; Nitin Roper

Dec 17, 2024